0001225208-20-000300.txt : 20200103
0001225208-20-000300.hdr.sgml : 20200103
20200103162145
ACCESSION NUMBER: 0001225208-20-000300
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200101
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pierce David A
CENTRAL INDEX KEY: 0001529751
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 20505774
MAIL ADDRESS:
STREET 1: BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2020-01-01
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001529751
Pierce David A
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP,Pres MedSurg
Common Stock
2020-01-01
4
M
0
11926.0000
0.0000
A
36127.0000
D
Common Stock
2020-01-01
4
F
0
3656.0000
45.2200
D
32471.0000
D
Common Stock
2020-01-02
4
S
0
2152.0000
45.5000
D
30319.0000
D
Performance Share Units
2020-01-01
4
M
0
11926.0000
0.0000
D
2019-12-31
2019-12-31
Common Stock
11926.0000
0.0000
D
On February 28, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2017 adjusted free cash flow measured against its 2017 financial plan over the one-year performance period ending December 31, 2017 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The Performance Share Units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2019.
This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
/s/ Scott G. Hodgdon, Attorney-in-Fact
2020-01-03